Sort
30,917 grants matching “tumor microenvironment”
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$394,328Hongjiao Ouyang · Texas A&M University Health Science Ctr · R01 · FY2017 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$394,322Gauri Varadhachary · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Engineering Nanomaterials to Prime Immunity
$394,303James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Causes and Consequences of Acid pH in Tumors
$394,303University Of Arizona · R01 · FY2003 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2018 · CA
Distinct Pathways of VPF/VEGF Receptors
$394,250Debabrata Mukhopadhyay · Mayo Clinic Rochester · R01 · FY2012 · HL
Distinct Pathways of VPF/VEGF Receptors
$394,250Debabrata Mukhopadhyay · Mayo Clinic Rochester · R01 · FY2011 · HL
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2017 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2016 · CA
Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis
$394,236Sohail F. Tavazoie · Rockefeller University · U54 · FY2022 · CA
Lipids and Myeloid Cell Function in Cancer
$394,195Luis J. Montaner · Wistar Institute · R01 · FY2022 · CA
Inflammation and immunity in the crucible of premalignancy
$394,185Adrian Erlebacher · New York University School Of Medicine · R01 · FY2014 · CA
Increasing Thiols for Improving T cell Immunotherapy
$394,167Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R41 · FY2022 · CA
IL13Ra2 targeted T-cell therapy for glioma
$394,125Irina V Balyasnikova · Northwestern University At Chicago · R21 · FY2015 · NS
Microenvironmental Control of Capillary Morphogenesis
$394,099Andrew J Putnam · University Of Michigan At Ann Arbor · R01 · FY2014 · HL
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
$394,043Ralph A. Reisfeld · Scripps Research Institute, The · R01 · FY2010 · CA
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
$394,043Ralph A. Reisfeld · Scripps Research Institute, The · R01 · FY2009 · CA
Function of IL35+ B cells in pancreatic cancer
$394,032Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2023 · CA
Role of senescence in multiple myeloma tumorigenesis
$394,000Megan M Weivoda · Mayo Clinic Rochester · U01 · FY2024 · AG
Managing Microenvironment-mediated Heterogeneity and Resistance
$393,992Laura Madeline Heiser · Oregon Health & Science University · U54 · FY2017 · CA
Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression
$393,956Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2024 · CA
A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer
$393,941David Francis Kashatus · University Of Virginia · U54 · FY2022 · CA
The integrated stress response and the microenvironment in melanoma progression
$393,894Constantinos Koumenis · University Of Pennsylvania · R01 · FY2024 · CA
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer
$393,846Roberta Faccio · Washington University · R01 · FY2024 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$393,773Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2023 · NS